Novel educational and goal-setting tool to improve knowledge of chronic kidney disease among liver transplant recipients: A pilot study

被引:5
|
作者
Leek, Rachael B. [1 ,2 ]
Park, Jeong M. [1 ,2 ]
Koerschner, Claire [3 ]
Mawby, Jennifer [3 ]
Sonnenday, Christopher J. [3 ]
Nunes, Julie A. Wright [4 ]
Sharma, Pratima [5 ]
机构
[1] Univ Michigan, Dept Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Michigan Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Surg, Michigan Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Div Nephrol, Michigan Med, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Div Gastroenterol & Hepatol, Michigan Med, Ann Arbor, MI 48109 USA
来源
PLOS ONE | 2019年 / 14卷 / 07期
关键词
STAGE RENAL-DISEASE; MANAGEMENT; IMPACT; TIME;
D O I
10.1371/journal.pone.0219856
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Liver transplant (LT) recipients have limited understanding of post-transplant chronic kidney disease (CKD) despite an excellent pre-existing framework of transplant care. This pilot study examined the efficacy and feasibility of a tailored educational and goal-setting tool in improving CKD knowledge among LT recipients with early-stage CKD. Methods In this prospective cohort study, we administered the CKD educational and goal-setting tool to 81 LT recipients between 7/1/2016 and 12/31/2017. We excluded patients with simultaneous liver-kidney transplantation, eGFR<30 ml/min, non-English speaking, on hemodialysis or listed for kidney transplantation. The pre- and post-education knowledge scores were compared using a paired t-test. Linear regression was used to assess the independent predictors of change in knowledge score. Results Mean age was 56.3 years, 69.1% were males, 85.2% were Caucasians and mean eGFR was 61.2 +/- 20.0 ml/min. The CKD educational and goal-setting tool improved the CKD knowledge scores among LT recipients (pre: 71.8 +/- 16.6%, post: 83.3 +/- 10.4%; p<0.001). In an adjusted model (r(2) = 0.75), those with lower pre-education knowledge scores had the most improvement in their post-education knowledge scores (beta = -83.2; p<0.001). Two-thirds stated their most important self-management goal and reported motivation to follow this goal. Time spent for the CKD education was approximately 15 minutes. Conclusions A simple LT-specific patient educational and goal-setting tool effectively improved CKD knowledge. Implementation of this tailored intervention will improve CKD awareness and may promote goal-setting in the target population.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Liver alone or simultaneous liver-kidney transplant? Pretransplant chronic kidney disease and post-transplant outcome - a retrospective study
    Nagai, Shunji
    Safwan, Mohamed
    Collins, Kelly
    Schilke, Randolph E.
    Rizzari, Michael
    Moonka, Dilip
    Brown, Kimberly
    Patel, Anita
    Yoshida, Atsushi
    Abouljoud, Marwan
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 (09) : 1028 - 1040
  • [32] A Patient Safety Educational Tool for Patients With Chronic Kidney Disease: Development and Usability Study
    Bowman, Cassandra
    Lunyera, Joseph
    Alkon, Aviel
    Boulware, L. Ebony
    Russell, Jennifer St Clair
    Riley, Jennie
    Fink, Jeffrey C.
    Diamantidis, Clarissa
    [J]. JMIR FORMATIVE RESEARCH, 2020, 4 (05)
  • [33] Discovery and Validation of an Early Post-Transplant Biomarker Model Predictive of Chronic Kidney Disease in Liver Transplant Recipients.
    Levitsky, J.
    Asrani, S.
    Klintmalm, G.
    Schiano, T.
    Moss, A.
    Chavin, K.
    Miller, C.
    Zhao, L.
    Guo, K.
    Bridges, N.
    Odim, J.
    Brown, M.
    Ikle, D.
    Armstrong, B.
    Abecassis, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 312 - 313
  • [34] A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipients
    Jorgenson, Margaret R.
    Descourouez, Jillian L.
    Leverson, Glen E.
    Saddler, Christopher M.
    Smith, Jeannina A.
    Garg, Neetika
    Parajuli, Sandesh
    Mandelbrot, Didier A.
    Odorico, Jon S.
    [J]. CLINICAL TRANSPLANTATION, 2021, 35 (10)
  • [35] Effect of mTOR inhibitors during CMV disease in kidney transplant recipients: Results of a pilot retrospective study
    Kaminski, Hannah
    Belanger, Juliette
    Mary, Julien
    Garrigue, Isabelle
    Acquier, Mathieu
    Dechanet-Merville, Julie
    Merville, Pierre
    Couzi, Lionel
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2020, 64 (07) : 520 - 531
  • [36] Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients.
    Kaiser, T. E.
    Ejaz, N. S.
    Tremblay, S.
    Parrish, N. J.
    Schinasi, S.
    Harris, J.
    Govil, A.
    Anwar, N.
    Alloway, R. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1033 - 1034
  • [37] Clinical Implementation of Different Strategies for Exercise-Based Rehabilitation in Kidney and Liver Transplant Recipients: A Pilot Study
    Ribeiro, Paula A. B.
    Gradassi, Mathieu
    Martin, Sarah-Maude
    Leenknegt, Jonathan
    Baudet, Mathilde
    Le, VyVan
    Pomey, Marie-Pascale
    Rakel, Agnes
    Tournoux, Francois
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (02) : 246 - 253
  • [38] The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study
    Serper, Marina
    Reese, Peter P.
    Patzer, Rachel R.
    Levitsky, Josh
    Wolf, Michael S.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 (08) : 870 - 879
  • [39] CMV prophylaxis with valganciclovir in CMV-seropositive kidney- and liver-transplant recipients:: A pilot study
    Weclawiack, Hugo
    Kamar, Nassim
    Mengelle, Catherine
    Guitard, Joelle
    Ribes, David
    Lavayssiere, Laurence
    Esposito, Laure
    Cointault, Olivier
    Durand, Dominique
    Rostaing, Lionel
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 206 - 206
  • [40] DACLATASVIR PLUS SOFOSBUVIR FOR CHRONIC HCV-INFECTED KIDNEY TRANSPLANT RECIPIENTS - A PILOT STUDY OF EFFICACY AND SAFETY
    Duerr, M.
    Staeck, O.
    Khadzhynov, D.
    Schrezenmeier, E.
    Lehner, L.
    Budde, K.
    Halleck, F.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 20